These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10472607)

  • 1. [The autologous transplantation of hematopoietic precursors on an outpatient basis: an analysis of its feasibility at the Hospital Clínic de Barcelona].
    Rives S; Carreras E; Rovira M; Montoto S; Urbano-Ispizua A; Martínez C; Perales M; Alvarez A; Esteve J; González M; Montserrat E
    Med Clin (Barc); 1999 Sep; 113(6):201-4. PubMed ID: 10472607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case-control comparison of at-home to total hospital care for autologous stem-cell transplantation for hematologic malignancies.
    Fernández-Avilés F; Carreras E; Urbano-Ispizua A; Rovira M; Martínez C; Gaya A; Granell M; Ramiro L; Gallego C; Hernando A; Segura S; García L; González M; Valverde M; Montserrat E
    J Clin Oncol; 2006 Oct; 24(30):4855-61. PubMed ID: 17001069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic stem cell transplantation with reduced-intensity conditioning is potentially feasible as an outpatient procedure.
    Subirà M; Sureda A; Ancín I; Martino R; Altés A; Brunet S; Sierra J
    Bone Marrow Transplant; 2003 Nov; 32(9):869-72. PubMed ID: 14561986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous hematopoietic stem cell transplants that utilize total body irradiation can safely be carried out entirely on an outpatient basis.
    Stiff P; Mumby P; Miler L; Rodriguez T; Parthswarthy M; Kiley K; Porter N; Batiste R; Wojtowitz S; Lichtenstein S; Fox-Geiman M; Toor A
    Bone Marrow Transplant; 2006 Dec; 38(11):757-64. PubMed ID: 17057729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose lenograstim to enhance engraftment after autologous stem cell transplantation: a prospective randomized evaluation of two different fixed doses.
    Suh C; Kim HJ; Kim SH; Kim S; Lee SJ; Lee YS; Kim EK; Kim SB; Lee JS; Kim MW; Kim K; Yoon SS
    Transfusion; 2004 Apr; 44(4):533-8. PubMed ID: 15043569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outpatient total body irradiation as a component of a comprehensive outpatient transplant program.
    Bredeson C; Perry G; Martens C; McDiarmid S; Bence-Bruckler I; Atkins H; Serna D; Hopkins H; Mikhael J; Genest P; Huebsch L
    Bone Marrow Transplant; 2002 Apr; 29(8):667-71. PubMed ID: 12180111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced charges and costs associated with outpatient autologous stem cell transplantation.
    Meisenberg BR; Ferran K; Hollenbach K; Brehm T; Jollon J; Piro LD
    Bone Marrow Transplant; 1998 May; 21(9):927-32. PubMed ID: 9613786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outpatient myeloablative allo-SCT: a comprehensive approach yields decreased hospital utilization and low TRM.
    Solomon SR; Matthews RH; Barreras AM; Bashey A; Manion KL; McNatt K; Speckhart D; Connaghan DG; Morris LE; Holland HK
    Bone Marrow Transplant; 2010 Mar; 45(3):468-75. PubMed ID: 19767781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outpatient autologous hematopoietic stem cell transplantation for patients with relapsed follicular lymphoma.
    Leger C; Sabloff M; McDiarmid S; Bence-Bruckler I; Atkins H; Bredeson C; Zhang H; Huebsch L
    Ann Hematol; 2006 Oct; 85(10):723-9. PubMed ID: 16832675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic impact of palifermin on the costs of hospitalization for autologous hematopoietic stem-cell transplant: analysis of phase 3 trial results.
    Elting LS; Shih YC; Stiff PJ; Bensinger W; Cantor SB; Cooksley C; Spielberger R; Emmanoulides C
    Biol Blood Marrow Transplant; 2007 Jul; 13(7):806-13. PubMed ID: 17580258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of caregivers limits use of outpatient hematopoietic stem cell transplant program.
    Frey P; Stinson T; Siston A; Knight SJ; Ferdman E; Traynor A; O'Gara K; Rademaker A; Bennett C; Winter JN
    Bone Marrow Transplant; 2002 Dec; 30(11):741-8. PubMed ID: 12439696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low transplant related mortality in older patients with hematologic malignancies undergoing autologous stem cell transplantation.
    Villela L; Sureda A; Canals C; Sanz MA; Martino R; Valcárcel D; Altés A; Briones J; Gómez M; Brunet S; Sierra J
    Haematologica; 2003 Mar; 88(3):300-5. PubMed ID: 12651269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of readmission in children receiving allogeneic hematopoietic stem cell transplantation: an institutional experience.
    Jaing TH; Tsay PK; Yang CP; Hung IJ; Wen YC; Tseng CK
    Transplant Proc; 2008 Dec; 40(10):3643-5. PubMed ID: 19100457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of inpatient and outpatient ASCT.
    Summers N; Dawe U; Stewart DA
    Bone Marrow Transplant; 2000 Aug; 26(4):389-95. PubMed ID: 10982285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conventional hematopoietic stem cell transplants from identical or alternative donors are feasible in recipients relapsing after an autograft.
    di Grazia C; Raiola AM; Van Lint MT; Lamparelli T; Gualandi F; Berisso G; Bregante S; Dominietto A; Mordini N; Bruno B; Frassoni F; Bacigalupo A
    Haematologica; 2001 Jun; 86(6):646-51. PubMed ID: 11418375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of an outpatient-based stem cell allotransplant program using nonmyeloablative conditioning regimens.
    Ruiz-Argüelles GJ; Gómez-Almaguer D; Ruiz-Argüelles A; González-Llano O; Cantú OG; Jaime-Pérez JC
    Am J Hematol; 2001 Apr; 66(4):241-4. PubMed ID: 11279633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conventional versus reduced-intensity conditioning regimen for allogeneic stem cell transplantation in patients with hematological malignancies.
    Valcárcel D; Martino R; Sureda A; Canals C; Altés A; Briones J; Sanz MA; Parody R; Constans M; Villela SL; Brunet S; Sierra J
    Eur J Haematol; 2005 Feb; 74(2):144-51. PubMed ID: 15654906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome of autologous stem cell transplantation in light chain deposition disease.
    Lorenz EC; Gertz MA; Fervenza FC; Dispenzieri A; Lacy MQ; Hayman SR; Gastineau DA; Leung N
    Nephrol Dial Transplant; 2008 Jun; 23(6):2052-7. PubMed ID: 18178602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outpatient allografting using non-myeloablative conditioning: the Mexican experience.
    Cantú-Rodríguez OG; Jaime-Pérez JC; Gutiérrez-Aguirre CH; González-Llano O; Mancías-Guerra C; Tarín-Arzaga LC; Ruiz-Delgado GJ; Sandoval-Villa CC; Marfil-Rivera J; Morales-Toquero A; Ruiz-Argüelles GJ; Gómez-Almaguer D
    Bone Marrow Transplant; 2007 Jul; 40(2):119-23. PubMed ID: 17530008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.